There are mixed reviews among the scientific community about whether CIRM’s close watch of their grantees is a good thing. To some, it is an important practice for public funding agencies such as CIRM to show the tax payers that their money is going towards productive and fruitful research. “I think the oversight is outstanding,” said John Simpson, the stem cell project director at the advocacy group Consumer Watchdog in California. “It shows that they’re not asleep at the switch. CIRM is functioning as both a grant making agency [and] also something of a steward of the funds it hands out.”
Continue reading...
Monday, November 16, 2009
0 Comments